We are hiring! Click to View Open Positions.

Posters & Presentations

September 2022

12th Annual World Clinical Biomarkers & CDx Summit

Development of a Comprehensive Biomarker Strategy for the Latent TGFβ1 Inhibitor SRK-181 Phase 1 Clinical Trial, DRAGON

View This Poster

September 2022

American College of Clinical Pharmacology Annual Meeting

Preliminary Population Pharmacokinetic Modeling of SRK-181 from Phase 1 Dose Escalation Study

View This Poster

July 2022

Federation of American Societies for Experimental Biology

Selective Targeting of Matrix-Associated TGFβ1 is an Attractive Approach for Anti-Fibrotic Therapy

View This Poster

June 2022

CURE SMA Annual Conference

Topaz Extension: 24-Month Efficacy and Safety: Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA)

View This Poster

June 2022

CURE SMA Annual Conference

Treatment Effects Among Patients with Type 2 and Type 3 SMA: Directly Reported by Patients and Caregivers from the TOPAZ Clinical Trial

View This Poster

April 2022

2022 European Paediatric Neurology Society Congress (EPNS)

Apitegromab in Spinal Muscular Atrophy (SMA): An Analysis of Multiple Efficacy Endpoints in the TOPAZ Trial (Presentation)

View This Poster